PACB Pacific Biosciences of Californ
$2.45▲ +8.89%
Healthcare
Other
After hours
$2.44▼ -0.41%
Oct 27, 5:48 PM ET
Volume 18.67M
Avg Volume (10D) 9.89M
Key Metrics & Fundamentals
Market Cap
$761.54M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.07 - 3.44
% vs 50 MA
41.08%
% vs 200 MA
53.03%
RSI-14
63.3
MACD Histogram
-0.0100
Beta (1Y vs SPY)
2.29
Free Cash Flow
-$39.19M
Gross Rev
$39.01M
Gross Profit
$12.64M
EBITDA
-$38.05M
COGS
$26.37M
Operating Exp
$57.25M
Operating Income
-$44.61M
EBIT
-$44.61M
Pretax Income
-$44.68M
Net Income
-$44.74M
EPS (Diluted)
-0.14
Price & Volume History
Loading chart…
Recent News

PacBio to Participate in Upcoming Investor Conferences
GlobeNewswire · Oct 27, 2026 4:05 PM ET

Here's Why You Should Hold PacBio Stock in Your Portfolio for Now
Zacks · Oct 27, 2026 1:29 PM ET

1 of Wall Street’s favorite stocks worth your attention and 2 we turn down
StockStory · Oct 27, 2026 1:26 PM ET

Pacific Biosciences of California (PACB) Declines More Than Market: Some Information for Investors
Zacks · Oct 22, 2026 5:15 PM ET
Pacific Biosciences of California, Verily Health Agree on Multi-Year Biomedical AI Collaboration
MT Newswires · Oct 19, 2026 9:42 AM ET

PacBio and Verily Health Announce Multi-Year Strategic Collaboration to Scale Long-Read Genomics for Biomedical AI
GlobeNewswire · Oct 19, 2026 9:05 AM ET

Azenta, Myriad Genetics, Moderna, Repligen, and PacBio Shares Plummet, What You Need To Know
StockStory · Oct 16, 2026 4:43 PM ET

Pacific Biosciences of California (PACB) Declines More Than Market: Some Information for Investors
Zacks · Oct 14, 2026 5:15 PM ET

PacBio to Report Third Quarter 2026 Financial Results on November 4, 2026
GlobeNewswire · Oct 14, 2026 4:05 PM ET

PacBio Teams With TychoBio to Advance AI-Driven RNA Therapeutics
Zacks · Oct 13, 2026 11:28 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See PACB's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.